Adherence to a medical regimen has been defined as the extent to which a patient's behavior coincides with clinical prescriptions. In liver transplant patients, adherence to immunosuppressive therapy and to medical indications in general is crucial for short-and long-term outcomes. Nonadherence to i
Kidney dysfunction in the recipients of liver transplants
β Scribed by Alan Wilkinson; Phuong-Thu Pham
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 77 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20618
No coin nor oath required. For personal study only.
β¦ Synopsis
Key
Points 1. Pretransplant kidney function is an important predictor of posttransplant kidney function. 2. Chronic kidney disease is present in 20% of liver transplant recipients by 5 years. 3. Kidney function is impacted by pretransplant management of the consequences of the hepatorenal syndrome. 4. The use of calcineurin inhibitor (CNI) -based immunosuppression is an important factor in the development of chronic kidney disease, and the use of mycophenolic acid -or sirolimus-based immunosuppression with reduced-dose CNI may be of benefit. (Liver Transpl 2005;11:S47-S51.)
Factors Affecting Posttransplant Renal Function
Postoperative acute renal failure occurs in 17% to 95% of patients undergoing orthotopic liver transplantation (OLT). The difference in the incidence reported may be due in part to the wide disparity in the criteria used to define "acute renal failure." Nonetheless the commonly suggested etiologies of postoperative acute renal failure include acute tubular necrosis secondary to ischemic or toxic insult to the kidneys, preexisting hepatorenal syndrome (HRS), and drug-induced interstitial nephritis. [1][2][3] The former may include prolonged hypotension, sepsis or septic shock, sustained prerenal renal failure, and use of nephrotoxic drugs. Acute renal failure or declining renal function associated with the use of cyclosporine or tacrolimus in the posttransplantation period has been well described and is discussed in more detail below. Preoperative renal dysfunction, delayed liver graft function or primary graft nonfunction, and higher serum bilirubin level have also been variably shown to predispose OLT recipients to postoperative acute renal failure. [3][4][5] Chronic renal insufficiency, or chronic kidney disease, has been reported to occur in 4% to more than 80% of OLT recipients. 1,[6][7][8] The wide range in the incidence reported may be partly due to the difference in the criteria used to define chronic renal failure as well as the difference in the duration of follow-up. The commonly suggested causes or risk factors for the development of progressive chronic kidney disease or endstage renal disease (ESRD) in long-term survivors of OLT include calcineurin inhibitor nephrotoxicity, pre-OLT HRS, preexisting renal insufficiency, and diabetes mellitus. 3,5,7,8 Postoperative acute renal failure, dialysis requirement in the pretransplantation and/or posttransplantation period, hepatitis C infection, and age have also been variably shown to be associated with an increased risk for the development of chronic kidney disease. [8][9][10][11] In a study conducted by Fisher et al., severe chronic renal
π SIMILAR VOLUMES
The purpose of this study was to compare the inci-dence and severity of rejection episodes in a group of dence and severity of rejection episodes in a group of children receiving living related orthotopic liver transchildren receiving living related orthotopic liver transplants (LRLT) versus patient
Long-term morbidity and survival after orthotopic liver transplantation (OLT) are to a large degree determined by cardiovascular disease and cancer. Tobacco use is a well-known risk factor for both. The aim of this study was to examine smoking behavior before and after OLT and to define groups at ri
Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no conse
1. The use of low-dose immunosuppressive therapy along with pre- and posttransplantation nucleos(t)ide therapy and posttransplantation hepatitis B immunoglobulin (HBIG) has yielded marked improvements in survival. 2. Lamivudine (Epivir-HBV), adefovir (Hepsera), entecavir (Baraclude), tenofovir (Vire
Liver transplantation is being evaluated as a therapeutic option for human immunodeficiency virus (HIV)-infected patients with end-stage liver disease, but experience is still scarce. We describe the outcome of 4 HIV-infected patients who underwent liver transplantation in our hospital between July